IL-24对小鼠黑色素瘤B16细胞抑制作用的实验研究
[Abstract]:Objective: To construct the eukaryotic expression plasmid pEGFP-N1-IL-24 containing the target gene IL-24 and to transfect the mouse melanoma B16 cells, and to study the effect of IL-24 on the apoptosis and in vitro proliferation of the tumor cells. Methods: pUC57-IL-24 was digested with restriction endonuclease and purified by agarose gel electrophoresis and then connected with pEGFP-N1, and the ligation product was transformed into competent cell E. coli DH5a. The plasmid was extracted, and the plasmid was extracted again, and the expression of IL-24 into pEGFP-N1 was examined. The pEGFP-N1-IL-24 was transfected into B16 cells (B16/ pEGFP-N1-IL-24 group) by the liposome method, and the untreated B16 cells (B16 groups) were also provided as the control group, and the B16 cells (B16/ Lip group), which were only added to the liposomes, were used as the liposome group, and the B16 cells transfected with pEGFP-N1 (B16/ pEGFP-N1 group) were used as the empty vectors. In the group, B16 cells (B16/ VCR group) with vincristine were added as the group of chemotherapeutic drugs. After 24 h, the expression of each group of cells was observed under a fluorescence microscope. After 48 h of transfection, the morphological changes of the cells were observed at high magnification in an inverted microscope, and the cells were detected by the method of orange/ ethidium bromide (AO/ EB). The in vitro proliferation ability of B16 cells was detected by MTT method, and the results of the experiment were expressed by x-% s. The statistical software was used for t-test, and there was a significant difference in P0.05. I'm different. Results:1. The constructed eukaryotic expression plasmid containing IL-24 was digested and electrophoresed, and the bands of 4.7 kb and 660bp were found to be consistent with the expected value, and the pEGFP-N1-IL-2 was verified by sequencing. 4 gene sequence.2. B16, B16/ Lip, B16/ pEGFP-N1, B16/ pEGFP-N1-IL-24 and B16/ VCR five-group cells were observed under a fluorescence microscope at 24 h after transfection, and the cells of B16/ pEGFP-N1 group and B16/ pEGFP-N1-IL-24 group were observed to emit green fluorescence, indicating that the EGFP gene was expressed in B16 cells, while the other groups were thin The cells were not seen with green fluorescence.3. Observe the cell morphology of B16, B16/ Lip, B16/ pEGFP-N1, B16/ pEGFP-N1-IL-24, B16/ VCR 5-group cells for 48 h after transfection, and the cells of the B16/ pEGFP-N1-IL-24 and B16/ VCR 5-group cells are full of field of view due to cell division and proliferation, and the cell size is similar, circular, elliptical or short-shuttle type, cell, the periphery of the B16/ pEGFP-N1-IL-24 and B16/ VCR group cells is clear, the periphery of the majority of the cells is relatively vague, the aggregation is closely gathered, the number of cells is small, The cells of B16, B16/ Lip, B16/ pEGFP-N1, B16/ pEGFP-N1-IL-24 and B16/ VCR were stained with AO/ EB double fluorescence respectively. The results showed that the cells in B16, B16/ Lip and B16/ pEGFP-N1 group were mostly nuclear chromatin with green and normal structure, with a small number of dead cells, i.e., nuclear staining. The color is red and the normal structure; B16/ pEGFP-N1-IL-24 and B16/ VCR group cells are mostly apoptotic cells, and the nuclear chromatin is orange or orange The ratio of B16, B16/ Lip, B16/ pEGFP-N1, B16/ pEGFP-N1-IL-24, B16/ VCR 5-group cells was determined by MTT, and the B16/ pEGFP-N1-IL-24 and B16/ Lip groups, B16/ pEGFP-N1-IL-24 and B16/ pEGFP-N1 had a significant difference (P0.05, P0.05), and the B16/ pEGFP-N1-IL-24 group and B16/ VCR group had no inhibition rate. Significant differences (P = 0.991). The histograms of B16/ pEGFP-N1-IL-24 and B16/ VCR group cells were seen to be different from B16/ Lip and B16/ pEGF in the B16/ pEGFP-N1-IL-24 group and B16/ VCR group cells, as can be seen from the histograms of the inhibition rate at 48 h after transfection. P-N Conclusion:1. The recombinant expression plasmid pEGFP-N1-IL-24 was successfully constructed and the recombinant expression plasmid pEGFP-N1-IL-24 was successfully constructed. And the exogenous IL-24 gene can be transfected into the mouse in vitro. Cytochrome B16 cells and expressed in B16 cells.3. Exogenous IL-24 gene can induce mouse black Cytochrome B16 cells apoptosis and inhibit their proliferation in vitro.4. IL-24
【学位授予单位】:延边大学
【学位级别】:硕士
【学位授予年份】:2011
【分类号】:R739.5
【相似文献】
相关期刊论文 前10条
1 李忠,王荣朝;小肠、口腔及肺多灶性无色素性黑色素瘤1例[J];江苏大学学报(医学版);1994年02期
2 汪九湘,刘文格;黑色素瘤与多发性骨髓瘤并存一例[J];河南肿瘤学杂志;1996年06期
3 杨维春,李世芳;脉络膜黑色素瘤术后9年单发肝脏转移病例报告[J];华北煤炭医学院学报;1999年03期
4 王卓才,赖日权,罗祝泉;肝恶性黑色素瘤1例[J];临床与实验病理学杂志;2001年06期
5 傅涛,魏文斌,王阳,刘小超;血清黑色素瘤活性抑制蛋白与葡萄膜黑色素瘤[J];中华眼底病杂志;2005年03期
6 杨秀珍;张晓梅;徐山淡;;颅内原发性黑色素瘤误诊一例[J];中华放射学杂志;2006年07期
7 杨景春,刘子勇,孙扬,苏肖汉,马远平;CO_2激光照射实验性黑色素瘤观察[J];中国医科大学学报;1986年Z1期
8 吕德志;钱俊甫;张友昌;;黑色素瘤误诊鸡眼一例[J];中国实用外科杂志;1988年08期
9 郭华北,,余裕民,姜程茂,蒋秉坤;血清S100IRMA对黑色素瘤的临床应用价值[J];标记免疫分析与临床;1995年04期
10 钟泽华,康晓丽,梅蓉;激光治疗足底黑色素瘤1例[J];华西医学;1995年03期
相关会议论文 前10条
1 吴缅;;MicroRNA调控黑色素瘤发生机制(英文)[A];第三届细胞结构与功能的信号基础研讨会论文摘要[C];2010年
2 赵连梅;韩丽娜;单保恩;;木鳖子提取物通过调节MAPKs通路诱导黑色素瘤B16细胞分化[A];河北省免疫学会第六次免疫学大会资料汇编[C];2010年
3 黎川;;黑色素瘤的MRI诊断[A];2010中华医学会影像技术分会第十八次全国学术大会论文集[C];2010年
4 许宇;赵培泉;朱颖;;视盘上的黑色素细胞瘤抑或是黑色素瘤[A];中国眼底病论坛·全国眼底病专题学术研讨会论文汇编[C];2008年
5 王国华;;恶性黑色素瘤胃转移的X线表现(附5例分析)[A];全国非血管性与血管性介入新技术学术研讨大会(第二届介入放射学新技术提高班、第二届河南省肿瘤介入诊疗学术大会)论文汇编[C];2004年
6 贾兰青;罗利群;张友会;;转导B_7-1基因消除IFN-γ对黑色素瘤转移潜力的增强作用[A];面向21世纪的科技进步与社会经济发展(下册)[C];1999年
7 胡巍;张超;方芸;;雾化吸入羟基喜树碱对小鼠黑色素瘤肺转移的药效学及体外作用机制研究[A];2010年江苏省药学大会暨第十届江苏省药师周大会论文集[C];2010年
8 王寅;林文;殷明;姜恅英;陈新生;;5—脂氧合酶对黑色素瘤A375粘附及整合素表达的作用[A];海峡两岸三地药理学学术报告会论文汇编[C];2001年
9 徐辉;唐桂波;;黑色素瘤脑转移的MRI表现[A];中华医学会第十三届全国放射学大会论文汇编(上册)[C];2006年
10 胡巍;张超;方芸;;雾化吸入羟基喜树碱对小鼠黑色素瘤肺转移的药效学及体外作用机制研究[A];2010施慧达杯第十届全国青年药学工作者最新科研成果交流会论文集[C];2010年
相关重要报纸文章 前10条
1 王伦 刘晨;探索黑色素瘤治疗新技术[N];保健时报;2009年
2 健康时报特约记者 管九苹;澳大利亚免费普查黑色素瘤[N];健康时报;2010年
3 实习生 易立;黑色素瘤,是否无药可治?[N];科技日报;2011年
4 本报记者 聂国春;专家:黑色素瘤可防可治[N];中国消费者报;2011年
5 记者 张e
本文编号:2439172
本文链接:https://www.wllwen.com/yixuelunwen/pifb/2439172.html